Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

BenevolentAI Reorganizes to Refocus on Serving Biopharma Industry Partners

Dec 11, 2024•over 1 year ago

Contract Type

partnership

United Kingdom

Description

BenevolentAI, an artificial intelligence biotech firm, has announced a reorganization to return to its original mission of serving biopharma industry partners. The changes include a refocus on core technologies for drug discovery and development.

Company Information

Company

BenevolentAI

Location

United Kingdom

About

The company has further backing from renowned UK entrepreneurs, including health tech success stories Tania Boler, CEO and Founder of Elvie; Dr. Jean Nehme, Co-Founder of Digital Surgery; and Sachin Dev Duggal, Founder of Builder.ai. “We draw on ancient wisdom and modern science, learning from the world’s leading experts, to guide people with the knowledge, skills, and tools to mitigate stress,” says the company in the press release.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for BenevolentAI's next move

Learn about Strategic plan

Agreement Insights

Based on industry data

Strategic partnership established

Partnership agreements typically involve technology integration and joint go-to-market strategies

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months